Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | XMD11-85h | GDSC1000 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | 0.0095 | 0.7 |
mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |